載入...
Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss
A growing appreciation of the overlapping neuroendocrine mechanisms controlling energy balance has highlighted combination therapies as a promising strategy to enhance sustained weight loss. Here, we investigated whether amylin- and glucagon-like-peptide-1 (GLP-1)-based combination therapies produce...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560126/ https://ncbi.nlm.nih.gov/pubmed/31186439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-44591-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|